{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:35:22Z","timestamp":1794958522279,"version":"4.9.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126319","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T10:44:36Z","timestamp":1725705876000},"page":"126319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inadvertent live vaccine administration in adult patients with inflammatory bowel disease on immunosuppressive therapy"],"prefix":"10.1016","volume":"42","author":[{"given":"Oscar Ramirez","family":"Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Farraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Hayney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Caldera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2024.126319_bb0005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO guidelines on the Prevention, diagnosis, and Management of Infections in inflammatory bowel disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126319_bb0010","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ibd\/izy366","article-title":"Serologic status of routine childhood vaccines, cytomegalovirus, and Epstein-Barr virus in children with inflammatory bowel disease","volume":"25","author":"deBruyn","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126319_bb0015","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.vaccine.2017.01.048","volume":"35","author":"Croce","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126319_bb0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00431-021-04283-w","article-title":"Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment \u2014 a systematic review","volume":"181","author":"Keller","year":"2022","journal-title":"Eur J Pediatr"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126319_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37602","article-title":"Safety and immunogenicity of live viral vaccines in a multicenter cohort of pediatric transplant recipients","volume":"6","author":"Feldman","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126319_bb0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","article-title":"Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept","volume":"48","author":"Borte","year":"2009","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126319_bb0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ajg.2016.21","article-title":"Safety and efficacy of live measles vaccine administered to a Crohn\u2019s disease patient receiving Vedolizumab","volume":"111","author":"Wichmann","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"50","key":"10.1016\/j.vaccine.2024.126319_bb0040","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1016\/j.vaccine.2020.10.028","article-title":"Varicella-zoster-virus vaccination of immunosuppressed children with inflammatory bowel disease or autoimmune hepatitis: a prospective observational study","volume":"38","author":"Seitel","year":"2020","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126319_bb0045","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.7326\/M20-6928","article-title":"The safety and immunologic effectiveness of the live varicella-zoster vaccine in patients receiving tumor necrosis factor inhibitor therapy: a randomized controlled trial","volume":"174","author":"Curtis","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2024.126319_bb0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fimmu.2015.00553","article-title":"Effector and central memory poly-functional CD4+ and CD8+ T cells are boosted upon ZOSTAVAX\u00ae vaccination","volume":"6","author":"Sei","year":"2015","journal-title":"Front Immunol"},{"issue":"14","key":"10.1016\/j.vaccine.2024.126319_bb0055","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00269-18","article-title":"Breadth and functionality of varicella-zoster virus glycoprotein-specific antibodies identified after Zostavax vaccination in humans","volume":"92","author":"Sullivan","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126319_bb0060","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.cmi.2017.12.025","article-title":"ESCMID study Group for Infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (soluble immune effector molecules [I]: anti-tumor necrosis factor-\u03b1 agents)","volume":"24","author":"Baddley","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2024.126319_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/DHPS.S28801","article-title":"Clinical use of anti-TNF therapy and increased risk of infections","volume":"5","author":"Ali","year":"2013","journal-title":"Drug, Healthc Patient Saf"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126319_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gutjnl-2014-307127","article-title":"Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results","volume":"64","author":"Wyant","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2024.126319_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.612830","article-title":"Vedolizumab: potential mechanisms of action for reducing pathological inflammation in inflammatory bowel diseases","volume":"9","author":"Luzentales-Simpson","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126319_bb0080","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/gut.2008.157339","article-title":"Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines","volume":"58","author":"Ben-Horin","year":"2009","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126319_bb0085","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","article-title":"Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety","volume":"2","author":"Dubinsky","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"RR-04","key":"10.1016\/j.vaccine.2024.126319_bb0090","first-page":"1","article-title":"Prevention C for DC and prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep: Morb Mortal Wkly Rep Recomm Rep"},{"issue":"RR-4","key":"10.1016\/j.vaccine.2024.126319_bb0095","article-title":"Prevention of varicella; recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"Series: MMWR Recomm Rep: Morb Mortal Wkly Rep Recomm Rep"},{"key":"10.1016\/j.vaccine.2024.126319_bb0100","author":"Kotton"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:41:35Z","timestamp":1741887695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24010016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":20,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24010016"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126319","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inadvertent live vaccine administration in adult patients with inflammatory bowel disease on immunosuppressive therapy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126319"}}